Literature DB >> 2157709

Regulation of N-acetylglucosaminyltransferase V activity. Kinetic comparisons of parental, Rous sarcoma virus-transformed BHK, and L-phytohemagglutinin-resistant BHK cells using synthetic substrates and an inhibitory substrate analog.

M M Palcic1, J Ripka, K J Kaur, M Shoreibah, O Hindsgaul, M Pierce.   

Abstract

Baby hamster kidney (BHK) cells transformed with Rous sarcoma virus, RS-BHK cells, demonstrate a 2.5-fold increase in the activity of N-acetylglucosaminyltransferase V (GlcNAc-T V, EC 2.4.1.155), and this increase in activity appears to be specific for this enzyme. By contrast, a lectin-resistant BHK cell line selected for its ability to grow in high levels of L-phytohemagglutinin, LP3.3, is characterized by a specific decrease in its GlcNAc-T V activity. To test if these alterations in the apparent Vmax of GlcNAc-T V are due to changes in the efficiency of populations of enzymes in RS-BHK and LP3.3 cells compared to the parental BHK cells, we have compared the kinetic properties of the enzymes from these three sources. The Km constants observed for both the sugar nucleotide donor (UDP-GlcNAc) and two synthetic trisaccharide acceptors were indistinguishable. The Vmax values toward three synthetic acceptors were also determined first for the BHK GlcNAc-T V, and they varied by over 5-fold. When these values were measured for the variant and transformed cell enzymes, however, similar 5-fold differences were still observed, although the absolute values for these acceptors were all higher or lower for the RS-BHK and LP3.3 enzymes, respectively. In addition, we have synthesized a deoxygenated analog of the specific GlcNAc-T V acceptor, beta GlcNAc(1,2) alpha Man(1,6) beta ManOR, where the reactive 6'-OH group has been removed, and the resulting trisaccharide was found to be a competitive inhibitor of the enzyme. The Ki for this inhibitor was near 70 microM for the GlcNAc-T V from all three sources. These kinetic comparisons demonstrate that the enzymes from the three cell types have kinetically indistinguishable active sites. These results suggest that the differences in the apparent Vmax values among the cell types are most likely due to alterations in the number of active molecules rather than in the modulation of either their catalytic activities or specificities.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2157709

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Glycoscience finally comes of age.

Authors:  Anthony H Merry; Catherine L R Merry
Journal:  EMBO Rep       Date:  2005-10       Impact factor: 8.807

Review 2.  Regulation of N-acetylglucosaminyltransferase V and Asn-linked oligosaccharide beta(1,6) branching by a growth factor signaling pathway and effects on cell adhesion and metastatic potential.

Authors:  M Pierce; P Buckhaults; L Chen; N Fregien
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

3.  Preparation of antisera to recombinant, soluble N-acetylglucosaminyltransferase V and its visualization in situ.

Authors:  L Chen; N Zhang; B Adler; J Browne; N Freigen; M Pierce
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

4.  Enhanced expression of the β4-galactosyltransferase 2 gene impairs mammalian tumor growth.

Authors:  M Tagawa; K Shirane; L Yu; T Sato; S Furukawa; H Mizuguchi; R Kuji; K Kawamura; N Takahashi; K Kato; S Hayakawa; S Sawada; K Furukawa
Journal:  Cancer Gene Ther       Date:  2014-06-06       Impact factor: 5.987

5.  Reduction in Golgi apparatus dimension in the absence of a residential protein, N-acetylglucosaminyltransferase V.

Authors:  Zhizhong Dong; Christian Zuber; Michael Pierce; Pamela Stanley; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2014-02       Impact factor: 4.304

6.  Expression cloning of a cDNA encoding UDP-GlcNAc:Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen.

Authors:  M F Bierhuizen; M Fukuda
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

7.  Tumor cell surface beta 1-6 branched oligosaccharides and lung metastasis.

Authors:  Y Lu; J C Pelling; W G Chaney
Journal:  Clin Exp Metastasis       Date:  1994-01       Impact factor: 5.150

8.  Substrate specificity and inhibition of UDP-GlcNAc:GlcNAc beta 1-2Man alpha 1-6R beta 1,6-N-acetylglucosaminyltransferase V using synthetic substrate analogues.

Authors:  I Brockhausen; F Reck; W Kuhns; S Khan; K L Matta; E Meinjohanns; H Paulsen; R N Shah; M A Baker; H Schachter
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

9.  Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V.

Authors:  M Demetriou; I R Nabi; M Coppolino; S Dedhar; J W Dennis
Journal:  J Cell Biol       Date:  1995-07       Impact factor: 10.539

10.  Structure and mechanism of cancer-associated N-acetylglucosaminyltransferase-V.

Authors:  Masamichi Nagae; Yasuhiko Kizuka; Emiko Mihara; Yu Kitago; Shinya Hanashima; Yukishige Ito; Junichi Takagi; Naoyuki Taniguchi; Yoshiki Yamaguchi
Journal:  Nat Commun       Date:  2018-08-23       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.